Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-25T07:58:57.263Z Has data issue: false hasContentIssue false

Nanocomposite Scaffolds for Bone Tissue Engineering: Design, Fabrication, Surface Modification and Sustained Release of Growth Factor

Published online by Cambridge University Press:  10 March 2011

Min Wang*
Affiliation:
Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong
Bin Duan
Affiliation:
Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong
*
*Corresponding author: memwang@hku.hk
Get access

Abstract

From the material point of view, the extracellular matrix (ECM) of bone is a natural nanocomposite consisting of an organic matrix (mainly collagen) and inorganic nanofillers (bone apatite) which are inserted in a parallel way into the collagen fibrils. For human bone tissue repair or regeneration, nanocomposites consisting of a biodegradable polymer matrix and nano-sized fillers such as bioactive ceramics or glasses, which mimic the hierarchical structure of bone, are considered a promising strategy. Combining living cells with biodegradable materials and/or bioactive component(s), the concept of tissue engineering first elucidated in the early 1990s represented a paradigm shift from tissue grafting, with autografts being the gold standard, or even completely from prosthesis implantation. In scaffold-based tissue engineering, scaffolds play an important role for tissue regeneration. Currently, acellular scaffolds with or without biomolecules such as growth factors are considered as an effective strategy for certain tissue repair due to their relatively low costs and easier process to gain surgeons’ acceptance and regulatory approval. In the current study, integrating an advanced manufacturing technique, nanocomposite material and controlled delivery of growth factor to form multifunctional tissue engineering scaffolds was investigated. Three-dimensional, osteoconductive and totally biodegradable calcium phosphate (Ca-P)/poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) nanocomposite scaffolds with customized architecture, controlled porosity and interconnecting pores were designed and fabricated using selective laser sintering (SLS). The surface of nanocomposite scaffolds was modified with gelatin and then heparin, which facilitated the incorporation of a growth factor, recombinant human bone morphogenetic protein-2 (rhBMP-2). Experimental results demonstrated the effectiveness of this strategy in guiding the osteogenic differentiation of mesenchymal stem cells. Together with osteoconductive nanocomposite material and controlled growth factor delivery, the use of SLS technique to form complex scaffolds provides a promising route towards individualized bone tissue regeneration.

Type
Research Article
Copyright
Copyright © Materials Research Society 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Mourino, V. and Boccaccini, A.R., J. R. Soc. Interface 7, 209 (2010).10.1098/rsif.2009.0379Google Scholar
2. Seunarine, K., Gadegaard, N., Tormen, M., O’Meredith, D., O’Riehle, M. and Wilkinson, C.D.W., Nanomedicine 1, 281 (2006).Google Scholar
3. Wan, W.B. and Shi, P.F., Artif. Organs 34, 339 (2010).Google Scholar
4. Hutmacher, D.W., Sittinger, M., Risbud, M.V., Trends Biotechnol.7, 354 (2004).Google Scholar
5. Naing, M.W., Chua, C.K., Leong, K.F. and Wang, Y., Rapid Prototyping J. 11, 249 (2005).10.1108/13552540510612938Google Scholar
6. Rimell, J.T. and Marquis, P.M., J. Biomed. Mater. Res. 53, 414 (2000).10.1002/1097-4636(2000)53:4<414::AID-JBM16>3.0.CO;2-M3.0.CO;2-M>Google Scholar
7. Wiria, F.E., Leong, K.F., Chua, C.K. and Liu, Y., Acta Biomater. 3, 1(2007)10.1016/j.actbio.2006.07.008Google Scholar
8. Simpson, R.L., Wiria, F.E., Amis, A.A., Chua, C.K., Leong, K.F., Hansen, U.N., Chandraselkaran, M. and Lee, M.W., J. Biomed. Mater. Res. Part B 84B, 17 (2008).10.1002/jbm.b.30839Google Scholar
9. Duan, B., Wang, M., Zhou, W.Y. and Cheung, W.L., Appl. Surf. Sci. 255, 529 (2008).10.1016/j.apsusc.2008.06.057Google Scholar
10. Duan, B., Wang, M., Zhou, W.Y., Cheung, W.L., Li, Z.Y. and Lu, W.W., Acta Biomater. 6, 4495 (2010).10.1016/j.actbio.2010.06.024Google Scholar
11. Zhou, W.Y., Lee, S.H., Wang, M., Cheung, W.L. and Ip, W.Y., J. Mater. Sci.-Mater. Med. 19 2535, (2008).10.1007/s10856-007-3089-3Google Scholar
12. Karageorgiou, V. and Kaplan, D., Biomaterials 26, 5474 (2005).10.1016/j.biomaterials.2005.02.002Google Scholar
13. Duan, B. and Wang, M., Polym. Degrad. Stabil. 95, 1655 (2010).10.1016/j.polymdegradstab.2010.05.022Google Scholar
14. Petite, H., Viateau, V., Bensaid, W., Meunier, A., de Pollak, C., Bourguignon, M., Oudina, K., Sedel, L. and Guillemin, G., Nat. Biotechnol. 18, 959 (2000).Google Scholar
15. Weir, M.D. and Xu, H.H.K., J. Biomed. Mater. Res. Part A, 94A, 223 (2010).10.1002/jbm.a.32665Google Scholar
16. Jeon, O., Kang, S.W., Lim, H.W., Chung, J.H. and Kim, B.S., Biomaterials 27, 1598 (2007).10.1016/j.biomaterials.2005.08.030Google Scholar
17. Chung, H.J., Kim, H.K., Yoon, J.J. and Park, T.G., Pharm. Res. 23, 1835 (2006).10.1007/s11095-006-9039-9Google Scholar
18. Beamish, J.A., Geyer, L.C., Haq-Siddiqi, N.A., Kottke-Marchant, K. and Marchant, R.E., Biomaterials 30, 6286 (2009).10.1016/j.biomaterials.2009.08.004Google Scholar
19. Chen, L., He, Z.Q., Chen, B., Yang, M.J., Zhao, Y.N., Sun, W.J., Xiao, Z.F., Zhang, J. and Dai, J.W., J. Mater. Sci.-Mater. Med. 21, 309 (2010).10.1007/s10856-009-3827-9Google Scholar
20. Zhao, L., Li, G., Chan, K.M., Wang, Y. and Tang, P.F., Calcif. Tissue Int. 84, 56 (2009).Google Scholar
21. Date, T., Doiguchi, Y., Nobuta, M. and Shindo, H., J. Orthop. Sci. 9, 503 (2004).10.1007/s00776-004-0815-2Google Scholar